Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1254 of 1,261

  1. US 6057158

    Adenovirus vectors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  2. US 6057298

    Keratin K1 expression vectors and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  3. US 6057125

    Clock gene and gene product

    The Board of Trustees of Northwestern University · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  4. US 6056968

    Pharmaceutical drug dosage forms providing different release rates

    Darwin Discovery Limited · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  5. US 6057300

    Methods for treating cancers and restenosis with p21

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  6. US 6057346

    Inhibition of retroviral LTR promoters by calcium response modifiers

    The United States of America, as represented by the Department of Health and Human Services · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  7. US 6057421

    Variable heavy and light chain regions of murine monoclonal antibody 1F7

    Immpheron, Inc. · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  8. US 6057104

    Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation

    Lexicon Genetics, Inc. · Granted May 2, 2000 · Expires Apr 27, 2020

    expired

  9. HU P9903958

    INSTANT VESICULAR PRODUCT

    ASTELLAS PHARMA EUROP B V [NL] · Granted Apr 28, 2000 · Expires Apr 23, 2020

    expired

  10. US 6054485

    Eye treatments using synthetic thyroid hormone compositions

    The Regents of the University of California · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  11. US 6054472

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  12. US 6054427

    Methods and compositions for optimization of oxygen transport by cell-free systems

    The Regents of the University of California · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  13. US 6054133

    Anti-microbial targeting for intracellular pathogens

    The Regents of the University of California · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  14. US 6054442

    Methods and compositions for modulation and inhibition of telomerase in vitro

    The Board of Regents of the University of Texas System · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  15. US 6054449

    Compounds and method for PDT of intimal hyperplasia and other diseases

    Miravant Pharmaceuticals, Inc. · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  16. US 6054567

    Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  17. US 6054486

    Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease

    UNITED TECHNOLOGY CORPORATION · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  18. US 6054560

    Mitogen activated protein kinase, FRK

    The Regents of the University of California · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  19. US 6054433

    Methods and compositions for stimulating tissue growth and epithelial moisturization

    The Regents of the University of California · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  20. US 6054293

    Semaphorin receptors

    The Regents of the University of California · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  21. US 6051405

    Constructs encoding recombinant antibody-toxin fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 18, 2000 · Expires Apr 13, 2020

    expired

  22. US 6051598

    Amino ceramide-like compounds and therapeutic methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 18, 2000 · Expires Apr 13, 2020

    expired

  23. US 6051432

    Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions

    I.D.M. Immuno-Designed Molecules · Granted Apr 18, 2000 · Expires Apr 13, 2020

    expired

  24. US 6051396

    Method for producing retinoblastoma gene protein products

    The Regents of the University of California · Granted Apr 18, 2000 · Expires Apr 13, 2020

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.